BTK and glioma: We compared BTK protein expression in serial FFPE-derived sections against expression of immune cell markers in various glioma tissue samples using antibodies to macrophage cells (CD163) and against the glioma cancer stem-like cell marker (SOX2) (representative images of various gliomas are shown in Figs 8–11 and S5–S9).